ArticleFrontiers in pharmacology2025

First-line treatment of hepatocellular carcinoma: a propensity-matched analysis of tyrosine kinase inhibitors combined with TACE, with or without PD-1 inhibitors.

Yanjun Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.